HT
LPCN icon

HAP Trading’s Lipocine LPCN Stock Holding History

HAP Trading’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,594
Closed -$3K – 1722
2022
Q3 		$3K Buy
7,594
+847
+13% +$9.46K ﹤0.01% 1537
2022
Q2 		$6K Sell
6,747
-700
-9% -$10.9K ﹤0.01% 1587
2022
Q1 		$23K Buy
+7,447
New +$156K ﹤0.01% 1504
2021
Q4 		– Sell
-1,565
Closed -$3K – 2722
2021
Q3 		$3K Sell
1,565
-94
-6% -$2.07K ﹤0.01% 2261
2021
Q2 		$5K Buy
1,659
+200
+14% +$4.7K ﹤0.01% 2145
2021
Q1 		$5K Sell
1,459
-500
-26% -$14.4K ﹤0.01% 1756
2020
Q4 		$4K Buy
1,959
+624
+47% +$15K ﹤0.01% 2055
2020
Q3 		$5K Buy
+1,335
New +$35.5K ﹤0.01% 1433

Other funds holding LPCN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return